Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

CSL Provides 2019 Full Year Results Presentation

14 Aug 2019  |  08:35:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: CSL Results Presentation

CSL provided 2019 full year results presentation. It reported a positive year for Company with revenue up 11% and profit after tax up 17%. There is a High patient demand for specialty products Haegarda and Kcentra. The FY 2019 China albumin sales were up 14%. There is a slight margin growth from plasma product mix shift, recombinant products growth and conclusion of HELIXATE in outlook for FY 2020.

Please click here for full details

See more ASX300 News Announcements